Carlisle Companies Incorporated filings document the regulatory record for an NYSE-listed building envelope products company with common stock trading under CSL. Form 8-K reports furnish quarterly operating results and disclose material events such as officer and director changes, compensation arrangements, share repurchase authorization, and completed public debt offerings.
The company’s proxy materials address board governance, shareholder voting matters, and executive compensation. Debt-related filings describe senior unsecured notes, including the 2035 and 2040 maturities, while securities disclosures identify Carlisle’s common stock and capital-structure terms.
Carlisle Companies executive Andrew C. Easton, VP & Chief Accounting Officer, reported equity awards on January 28, 2026. He received 225 shares of common stock as a restricted stock grant from the issuer, bringing his directly held common shares to 772.
He was also granted 780 employee stock options with a $341.01 exercise price, each for one share of common stock. These options vest in three equal annual installments beginning on January 28, 2027, and expire on January 27, 2036. All reported holdings are owned directly.
Carlisle Companies reported that President CCM Jason L. Taylor received new equity awards on January 28, 2026. He was granted 990 shares of restricted common stock for his services as an officer, at a grant price of $0, bringing his directly held common stock to 4,118 shares.
He also received an employee stock option for 3,465 shares of common stock with an exercise price of $341.01 per share. This option vests in three equal annual installments beginning on January 28, 2027, and he directly holds all 3,465 options after this grant.
Carlisle Companies executive Christopher Burke Gaskill received new equity awards. On January 28, 2026, he was granted 865 shares of common stock as restricted shares from the issuer in his role as an executive officer.
On the same date, he also received an employee stock option for 3,025 shares of Carlisle common stock at an exercise price of $341.01 per share, expiring on January 27, 2036. This option vests in three equal annual installments beginning on January 28, 2027, and all reported holdings are listed as directly owned.
Carlisle Companies executive Susan Wallace, VP & CHRO, reported new equity awards. On January 28, 2026, she received a grant of 675 shares of restricted common stock, bringing her directly held common shares to 2,026.
She was also granted an employee stock option for 2,355 shares of common stock with an exercise price of $341.01 per share. The option vests in three equal annual installments beginning on January 28, 2027, aligning her compensation more closely with long-term shareholder value.
Carlisle Companies executive Juan Sifontes, VP of Carlisle Operating System, reported equity awards from the company. On January 28, 2026, he received 220 shares of common stock as a restricted stock grant, increasing his directly owned common shares to 720.
He was also granted an employee stock option for 770 shares of Carlisle common stock at an exercise price of $341.01 per share. This option becomes exercisable in three equal annual installments beginning on January 28, 2027, and covers 770 shares held as a direct derivative position.
Carlisle Companies executive David W. Smith, VP, Sustainability, reported new equity awards. On January 28, 2026 he received a grant of 190 shares of common stock as restricted shares, bringing his directly held common stock to 3,527 shares, including 28 shares acquired through the company’s defined contribution plan during the prior year.
He was also granted an employee stock option covering 670 shares of Carlisle common stock at an exercise price of $341.01 per share. The option becomes exercisable in three equal annual installments beginning on January 28, 2027 and expires on January 27, 2036. Both the stock and option holdings are reported as directly owned.
Carlisle Companies executive Mehul Patel, VP of Investor Relations, reported new equity awards from the company. On January 28, 2026, he received a grant of 225 shares of common stock, described as restricted shares awarded for his services as an executive officer. After this grant, he held 1,040 common shares directly. He was also granted an employee stock option for 785 shares of common stock at an exercise price of $341.01 per share, expiring on January 27, 2036. The option vests in three equal annual installments beginning January 28, 2027.
Carlisle Companies Inc. VP & Chief Financial Officer Kevin P. Zdimal reported new equity awards. On 01/28/2026 he received a grant of 1,830 shares of common stock for services as an executive officer, recorded at a price of $0 per share as a compensatory award. Following this grant, he beneficially owned 43,432 common shares, which include 57 shares previously acquired through the company’s defined contribution plan.
On the same date, he was also granted an employee stock option to buy 6,405 shares of common stock at an exercise price of $341.01 per share. The option award was recorded at $0 for the transaction price and will vest in three equal annual installments beginning on January 28, 2027.
Carlisle Companies executive Frank J. Ready reported equity awards. On January 28, 2026, he received 980 shares of common stock as restricted stock granted for his services as an executive officer, bringing his directly held common shares to 6,490.
He was also granted an option to buy 3,430 shares of common stock at an exercise price of $341.01 per share. The option vests in three equal annual installments beginning on January 28, 2027 and expires on January 27, 2036.
Carlisle Companies Inc. reported new equity awards to Vice Chair Stephen Schwar. On January 28, 2026, he received a grant of 990 restricted shares of common stock at a stated price of $0, increasing his directly held common stock to 12,170 shares.
On the same date, he was also granted an employee stock option for 3,465 shares of common stock with an exercise price of $341.01 per share. This option vests in three equal annual installments beginning on January 28, 2027 and expires on January 27, 2036. His 12,170 common shares include 48 shares from a defined contribution plan and 7 shares from a dividend reinvestment plan acquired during the prior year.